What are the Key Drivers of Reimbursement for Biosimilars? An Examination of Reimbursement Processes and Recommendations Across Nine Countries
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.003
https://www.valueinhealthjournal.com/article/S1098-3015(13)01908-6/fulltext
Title :
What are the Key Drivers of Reimbursement for Biosimilars? An Examination of Reimbursement Processes and Recommendations Across Nine Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01908-6&doi=10.1016/j.jval.2013.08.003
First page :
A323
Section Title :
Health Care Expenditure or Reimbursement Studies – Biologics
Open access? :
No
Section Order :
5